Friday, July 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ARCTURUS THERAPEUTICS, INC.”

54 pharma patents match "ARCTURUS THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 54
Index total 30,257
Page 2 / 3

Quick answer

This filtered view shows 54 pharmaceutical patents matching "ARCTURUS THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

54 results for “ARCTURUS THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 10815463

    Messenger UNA molecules and uses thereof

    ARCTURUS THERAPEUTICS, INC. · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  2. US 10781169

    Method of synthesis of an ionizable cationic lipid

    ARCTURUS THERAPEUTICS, INC. · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  3. US 10731154

    Acyl-amino-LNA and/or hydrocarbyl-amino-LNA oligonucleotides

    ARCTURUS THERAPEUTICS, INC. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  4. US 10683500

    UNA oligomers having reduced off-target effects in gene silencing

    ARCTURUS THERAPEUTICS, INC. · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  5. US 10604758

    Therapeutic oligomers for treating amyloidosis

    ARCTURUS THERAPEUTICS, INC. · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted

  6. US 10556861

    Ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  7. US 10519447

    Therapeutic UNA oligomers and uses thereof

    ARCTURUS THERAPEUTICS, INC. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  8. US 10487105

    Trinucleotide MRNA cap analogs

    ARCTURUS THERAPEUTICS, INC. · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted

  9. US 10457945

    UNA oligomers for therapeutics with prolonged stability

    ARCTURUS THERAPEUTICS, INC. · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted

  10. US 10421964

    UNA oligomers and compositions for treating amyloidosis

    ARCTURUS THERAPEUTICS, INC. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted

  11. US 10399937

    Ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted

  12. US 10383952

    Ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Aug 20, 2019 · Expires Aug 15, 2039

    granted

  13. US 10369232

    Allele selective gene editing and uses thereof

    ARCTURUS THERAPEUTICS, INC. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted

  14. US 10227302

    Ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Mar 12, 2019 · Expires Mar 7, 2039

    granted

  15. US 9982259

    Transthyretin allele selective UNA oligomers for gene silencing

    ARCTURUS THERAPEUTICS, INC. · Granted May 29, 2018 · Expires May 24, 2038

    granted

  16. US 9962449

    MultiLigand agent for drug delivery

    ARCTURUS THERAPEUTICS, INC. · Granted May 8, 2018 · Expires May 3, 2038

    granted

  17. US 9951002

    Ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Apr 24, 2018 · Expires Apr 19, 2038

    granted

  18. US 9944929

    UNA single stranded oligomers for therapeutics

    ARCTURUS THERAPEUTICS, INC. · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  19. US 9896413

    Ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Feb 20, 2018 · Expires Feb 15, 2038

    granted

  20. US 9856475

    Formulations for treating amyloidosis

    ARCTURUS THERAPEUTICS, INC. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  21. US 9850202

    Ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted

  22. US 9670152

    Ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted

  23. US 9593077

    Ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

  24. US 9580711

    Lipid particles with asymmetric cationic lipids for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.